SANDOSTATIN LAR VS. SURGERY IN ACROMEGALICS WITH MACROADENOMA
$0Z01FY2000DKNIH
Diabetes, Digestive, Kidney Diseases
Investigators
Abstract
This new protocol, comparing long-acting somatostatin versus surgery, was begun under Dr. Derek LeRoith. No patients have as yet been recruited.
View original record on NIH RePORTER →